Equilizing Prescription Drug Prices World Wide
President Trump pledged to lower prescription drug prices in the U.S. in his State of the Union speech, and explained lower prices in several different nations for identical drugs as “very, very unfair.”
We don’t know precisely how the Trump government will proceed. But it’s necessary to understand what opportunities exist, and what’s at stake for the development of new medicines, in rebalancing international drug prices.
High drug costs in the U.S. help pharmaceutical innovators cover the high cost of bringing a new drug to market — more than $2 billion each based on several independent estimates. While Americans carry that load at pharmacy stations and pay high insurance premiums and deductibles, Europeans get access to new drugs at deeply …
... Read More